Karina Putineanu, MD

Dr. Anna-Karina (Karina) Putineanu, MD, is a Senior Medical Director for Infectious Diseases and Critical Care and is based in Brussels, Belgium. Dr.

Kamal Saini, MD

Kamal Saini, MD, Vice president at Fortrea Inc., is a board-certified medical oncologist based in Cambridge, United Kingdom, where he also practices part-time at the Addenbrooke’s (Cambridge Universi

José Espinoza, MD

José Espinoza, MD, is a Senior Medical Director, Therapeutic Area/Oncology at Fortrea, based in Madrid, Spain. Dr.

Jose Daniel Fanjul Fuente, MD

Jose Daniel Fanjul Fuente, MD, is a Medical Director, Oncology, for Fortrea, based in Madrid, Spain.

Jinju Kim, MD, PhD

Jinju Kim, MD, PhD, is a Medical Director of Oncology for Fortrea, based in Seoul, Korea. Dr.

Jeanelle Kam, MD, MBA, CPI

Dr. Kam is a trained OB/GYN with more than a decade of CRU early drug development experience across multiple indications. As a Certified Physician Investigator (CPI) and Medical Director at the Phase I Dallas CRU, Dr.

Isabella Presch, MD, MBA

Isabella Presch, MD, MBA, is a Senior Medical Director.

Ines Pagel-Langenickel, MD

Ines Pagel-Langenickel, MD, is an Executive Medical Director of CVMER (cardiovascular, metabolic, endocrine and renal) at Fortrea.

Hannah Simonds

Hannah Simonds is Director of Patient Recruitment and Engagement at Fortrea, having joined the organization in June 2020.

George Vamvakias

• 33 years in industry with experience in pharmaceutical and medical device product development